Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With

Luca Paolucci1, Fabio Mangiacapra1, Michele Mattia Viscusi1

  • 1Department of Cardiovascular Sciences, Campus-Biomedico University, Rome, Italy.

Insights

Incomplete revascularization after percutaneous coronary intervention (PCI) combined with elevated cardiac troponin (cTn) significantly increases major adverse cardiac events (MACE). Patients with incomplete revascularization are a high-risk subgroup needing closer monitoring.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Clinical outcomes of periprocedural myocardial injury with incomplete revascularization (IR) post-percutaneous coronary intervention (PCI) remain understudied.
  • Understanding the impact of myocardial injury and revascularization completeness is crucial for patient management.

Purpose of the Study:

  • To evaluate the association between post-PCI cardiac troponin (cTn) elevation thresholds, revascularization completeness, and long-term clinical outcomes.
  • To identify high-risk patient subgroups following PCI.

Main Methods:

  • 1061 patients undergoing PCI for stable coronary artery disease were analyzed.
  • Incomplete revascularization (IR) was defined by a residual SYNTAX score (rSS) >4.
  • Myocardial injury thresholds were set at 5×, 35×, and 70× the upper reference limit (URL) of baseline cTn.

Main Results:

  • Incomplete revascularization (IR) occurred in 23.4% of patients; major myocardial injury in 50.9%.
  • High preprocedural SYNTAX scores increased the risk of IR and myocardial injury.
  • IR combined with cTn elevation >35× URL or >70× URL significantly increased the risk of major adverse cardiac events (MACE) at two years.

Conclusions:

  • Periprocedural myocardial injury is strongly linked to MACE in PCI patients with IR.
  • Patients with incomplete revascularization after PCI represent a high-risk group.
  • Further investigation into managing myocardial injury in IR patients is warranted.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23